Gene · 7939
Papers2,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,932
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cross-Communication Between Knee Osteoarthritis and Fibrosis: Molecular Pathways and Key Molecules. | Open Access J Sports Med | 2022 | 35261547 | PubTator, text mining | PubMed |
| Multiscale Invasion Assay for Probing Macrophage Response to Gram-Negative Bacteria. | Front Chem | 2022 | 35242744 | PubTator, text mining | PubMed |
Reduction on Proinflammatory Cytokines after Application of Transcutaneous Electrical Nerve Stimulation (TENS) in Patients with a Breast Cancer: A Nonrandomized, Open, and Single-Arm Study Protocol with Paired Analysis. | Mediators Inflamm | 2022 | 35241969 | PubTator, text mining | PubMed |
| Ultrahigh-Throughput Sample Analysis Using Liquid Atmospheric Pressure Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry. | Anal Chem | 2022 | 35234449 | PubTator, text mining | PubMed |
| Conditional deletion of myeloid-specific mitofusin 2 but not mitofusin 1 promotes kidney fibrosis. | Kidney Int | 2022 | 35227692 | PubTator, text mining | PubMed |
| The physiological and clinical importance of cardiorespiratory fitness in people with abdominal aortic aneurysm. | Exp Physiol | 2022 | 35224790 | PubTator, text mining | PubMed |
| Bioprinting of Chondrocyte Stem Cell Co-Cultures for Auricular Cartilage Regeneration. | ACS Omega | 2022 | 35224351 | PubTator, text mining | PubMed |
| Complex peptide natural products: Biosynthetic principles, challenges and opportunities for pathway engineering. | Synth Syst Biotechnol | 2022 | 35224231 | PubTator, text mining | PubMed |
| Immunomodulatory and Anti-Inflammatory Properties of Selenium-Containing Agents: Their Role in the Regulation of Defense Mechanisms against COVID-19. | Int J Mol Sci | 2022 | 35216476 | PubTator, text mining | PubMed |
| Inflammation Is Present, Persistent and More Sensitive to Proinflammatory Triggers in Celiac Disease Enterocytes. | Int J Mol Sci | 2022 | 35216089 | PubTator, text mining | PubMed |
| Recent Developments in Hyaluronic Acid-Based Hydrogels for Cartilage Tissue Engineering Applications. | Polymers (Basel) | 2022 | 35215752 | PubTator, text mining | PubMed |
| Gelatin Methacrylate Hydrogel for Tissue Engineering Applications-A Review on Material Modifications. | Pharmaceuticals (Basel) | 2022 | 35215284 | PubTator, text mining | PubMed |
| The 3D Bioprinted Scaffolds for Wound Healing. | Pharmaceutics | 2022 | 35214197 | PubTator, text mining | PubMed |
| Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies. | Cancers (Basel) | 2022 | 35205760 | PubTator, text mining | PubMed |
| Methacrylated Cartilage ECM-Based Hydrogels as Injectables and Bioinks for Cartilage Tissue Engineering. | Biomolecules | 2022 | 35204718 | PubTator, text mining | PubMed |
| Additive Soft Matter Design by UV-Induced Polymer Hydrogel Inter-Crosslinking. | Gels | 2022 | 35200499 | PubTator, text mining | PubMed |
| Outcomes and Cost Analysis of Robotic Versus Laparoscopic Abdominoperineal Resection for Rectal Cancer: A Case-Matched Study. | Dis Colon Rectum | 2022 | 35195554 | PubTator, text mining | PubMed |
| Families' healthcare experiences for children with inherited metabolic diseases: protocol for a mixed methods cohort study. | BMJ Open | 2022 | 35193919 | PubTator, text mining | PubMed |
| Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells. | Cancer Biol Ther | 2022 | 35188070 | PubTator, text mining | PubMed |
| Fibrin-based factor delivery for therapeutic angiogenesis: friend or foe? | Cell Tissue Res | 2022 | 35175429 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7939/papers?page=45